‹ BBIO latest research

BBIO (BridgeBio Pharma, Inc.): every AI call and what happened next

TradeFlare's AI research teams analysed BBIO on 4 market nights between August 3, 2026 and August 26, 2026. Each row is that night's verdict, the price that day, and how the price actually moved afterwards — wins and misses alike. Nothing is edited after the fact.

4 calls 4 BUY · 0 HOLD · 0 SELL BUY calls up after 20 trading days: 0 of 4
DateVerdictPriceTarget / stop5 days later20 days laterWhy (that night)
August 26, 2026 BUY $80.40 $95.40 / $67.58 -3.6% -16.5%
The fundamental and sentiment teams are bullish, suggesting a longer-term upward trend is possible, but technicals are neutral and risk is high, warranting a shorter-term trade.
August 18, 2026 BUY $79.89 — / — -3.1% -17.7%
The current market regime and stock-specific factors do not support a new entry.
August 17, 2026 BUY $79.86 — / — +1.5% -14.4%
The current setup does not meet the criteria for a buy.
August 3, 2026 BUY $80.09 — / — +5.9% -4.2%
The stock is currently in a neutral market environment and the technicals are mixed, warranting a cautious approach.

Prices are daily closes. "Days later" counts trading days from the close on the day of the call. A HOLD is not a recommendation to buy; only published signals are tracked with a target and stop on the public record. How the research works. Updated October 14, 2026. AI-generated research for educational purposes — it can be wrong and is not financial advice.